Grant: CIHR-ICRH Travel Awards - ICRH / Vascular pool
University of British Columbia
$1,500.00
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
FY 2023-24
Summary
Sudden cardiac arrest (SCA) is a devasting heart event with a 10% survival rate. In young persons and athletes, inherited arrhythmias may account for up to 50% of unexplained SCA cases. In 2021, a distinct inherited arrhythmia syndrome, called calcium release deficiency syndrome (CRDS), was described in patients carrying loss-of-function RyR2 variants. These patients present with SCA but appear normal on the exercise stress test. As a newly discovered arrhythmia syndrome, there is a tremendous gap in knowledge about disease mechanisms, diagnostics, and appropriate treatments, which must be addressed to avoid preventable morbidity and mortality. We have developed, to our knowledge, the world's first human stem-cell based heart model to understand the molecular mechanisms of this disease, perform "clinical trials in a dish" to identify candidate treatments, and test out various electrical stimulation protocols that could be applied in clinical electrophysiology (EP) labs.
Department
Program
CIHR-ICRH Travel Awards - ICRH / Vascular pool
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
495592
Name
Dababneh Saif
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases
Projecttitle
DEVELOPING A HUMAN STEM CELL-DERIVED HEART MODEL TO CHARACTERIZE A NOVEL ARRHYTHMIA SYNDROME
Programtype2
Undefined
Orgnameinp2
University of British Columbia
Cihramount2
$1,500
Cihrequipment2
$0
Programname2
CIHR-ICRH Travel Awards - ICRH / Vascular pool
Keyworddelim
Calcium Release Deficiency Syndrome
Abstract
Sudden cardiac arrest (SCA) is a devasting heart event with a 10% survival rate. In young persons and athletes, inherited arrhythmias may account for up to 50% of unexplained SCA cases. In 2021, a distinct inherited arrhythmia syndrome, called calcium release deficiency syndrome (CRDS), was described in patients carrying loss-of-function RyR2 variants. These patients present with SCA but appear normal on the exercise stress test. As a newly discovered arrhythmia syndrome, there is a tremendous gap in knowledge about disease mechanisms, diagnostics, and appropriate treatments, which must be addressed to avoid preventable morbidity and mortality. We have developed, to our knowledge, the world's first human stem-cell based heart model to understand the molecular mechanisms of this disease, perform "clinical trials in a dish" to identify candidate treatments, and test out various electrical stimulation protocols that could be applied in clinical electrophysiology (EP) labs.
Competitiondate
202309
Approvedterm2
1 yr 0 mth
Pinamesdelim
Dababneh, Saif
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $1,500~ $0~